AU3752700A - Novel methods of diagnosing and treating breast cancer, compositions, and methods of screening for breast cancer modulators - Google Patents

Novel methods of diagnosing and treating breast cancer, compositions, and methods of screening for breast cancer modulators

Info

Publication number
AU3752700A
AU3752700A AU37527/00A AU3752700A AU3752700A AU 3752700 A AU3752700 A AU 3752700A AU 37527/00 A AU37527/00 A AU 37527/00A AU 3752700 A AU3752700 A AU 3752700A AU 3752700 A AU3752700 A AU 3752700A
Authority
AU
Australia
Prior art keywords
breast cancer
methods
diagnosing
screening
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37527/00A
Inventor
Kurt C. Gish
David Mack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EOS Biotechnology Inc
Original Assignee
EOS Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EOS Biotechnology Inc filed Critical EOS Biotechnology Inc
Publication of AU3752700A publication Critical patent/AU3752700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU37527/00A 1999-03-15 2000-03-15 Novel methods of diagnosing and treating breast cancer, compositions, and methods of screening for breast cancer modulators Abandoned AU3752700A (en)

Applications Claiming Priority (18)

Application Number Priority Date Filing Date Title
US26886599A 1999-03-15 1999-03-15
US09268865 1999-03-15
US43987899A 1999-11-12 1999-11-12
US44037099A 1999-11-12 1999-11-12
US09440370 1999-11-12
US09439878 1999-11-12
US44049399A 1999-11-15 1999-11-15
US09440493 1999-11-15
US44067699A 1999-11-16 1999-11-16
US44067799A 1999-11-16 1999-11-16
US09440676 1999-11-16
US09440677 1999-11-16
US45081099A 1999-11-29 1999-11-29
US09450810 1999-11-29
US45313799A 1999-12-02 1999-12-02
US09453137 1999-12-02
PCT/US2000/006952 WO2000055629A2 (en) 1999-03-15 2000-03-15 Methods of diagnosing and treating breast cancer
USNOTGIVEN 2003-10-02

Publications (1)

Publication Number Publication Date
AU3752700A true AU3752700A (en) 2000-10-04

Family

ID=27575318

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37527/00A Abandoned AU3752700A (en) 1999-03-15 2000-03-15 Novel methods of diagnosing and treating breast cancer, compositions, and methods of screening for breast cancer modulators

Country Status (4)

Country Link
EP (1) EP1159619A2 (en)
AU (1) AU3752700A (en)
CA (1) CA2368152A1 (en)
WO (1) WO2000055629A2 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2317704T3 (en) 1998-09-02 2009-04-16 Diadexus, Inc. A NEW METHOD FOR DIAGNOSIS, FOLLOW-UP, STAFF. IMAGINARY AND TREATMENT OF DIFFERENT CANCERES.
US6902892B1 (en) 1998-10-19 2005-06-07 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US7888477B2 (en) 1998-12-17 2011-02-15 Corixa Corporation Ovarian cancer-associated antibodies and kits
US6962980B2 (en) 1999-09-24 2005-11-08 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
US6468546B1 (en) 1998-12-17 2002-10-22 Corixa Corporation Compositions and methods for therapy and diagnosis of ovarian cancer
AU1777201A (en) * 1999-11-16 2001-05-30 Eos Biotechnology, Inc. Novel methods of diagnosing and determining prognosis of breast cancer, compositions, and methods of screening for breast cancer modulators
US7238471B1 (en) 1999-11-23 2007-07-03 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating breast cancer
CA2390802A1 (en) * 1999-11-23 2001-05-31 Diadexus, Inc. A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer
KR20020073181A (en) 2000-01-25 2002-09-19 제넨테크, 인크. LIV-1 Related Protein, Polynucleotides Encoding the Same and Use Thereof for Treatment of Cancer
US7534417B2 (en) 2000-02-24 2009-05-19 Agensys, Inc. 103P2D6: tissue specific protein highly expressed in various cancers
GB0004576D0 (en) * 2000-02-25 2000-04-19 Oxford Glycosciences Uk Ltd Proteins
US20020102641A1 (en) * 2000-03-24 2002-08-01 Susan Schia Vi Oncogenic osteomalacia-related gene 1
EP1287129A1 (en) * 2000-05-19 2003-03-05 F.Hoffmann-La Roche Ag A process for determing the tumoricidal potential of a sample by the use of a nucleic acid which is downregulated in human tumor cells
US20060063230A1 (en) 2000-12-27 2006-03-23 Roman Naworth Sulfatases and methods of use thereof
US20030148920A1 (en) * 2000-12-27 2003-08-07 Steven Rosen Sulfatases and methods of use thereof
AU2002250143A1 (en) * 2001-03-16 2002-10-03 Eli Lilly And Company Lp mammalian proteins; related reagents
US6461847B1 (en) * 2001-03-19 2002-10-08 Applera Corporation Polynucleotides encoding human estrone sulfatases
US7465553B2 (en) 2001-12-31 2008-12-16 Dana-Farber Cancer Institute, Inc. Psoriasin expression by breast epithelial cells
EP2261368A1 (en) * 2002-03-13 2010-12-15 Genomic Health, Inc. Gene expression profiling in biopsied tumor tissues
CN1839205B (en) * 2003-05-29 2012-05-16 千年药品公司 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
EP2026071B1 (en) 2004-02-19 2013-07-31 Yale University Identification of cancer protein biomarkers using proteomic techniques
CA2580795A1 (en) * 2004-09-22 2006-04-06 Tripath Imaging, Inc. Methods and compositions for evaluating breast cancer prognosis
US8093362B2 (en) 2005-12-06 2012-01-10 Kyowa Hakko Kirin Co., Ltd. Anti-PERP recombinant antibody

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993003741A1 (en) * 1991-08-22 1993-03-04 Becton, Dickinson & Company Methods and compositions for cancer therapy and for prognosticating responses to cancer therapy
DE69737788T2 (en) * 1996-10-31 2008-03-13 Abbott Laboratories, Abbott Park REAGENTS AND METHODS FOR DETECTING CHEST DISORDERS
WO1998034118A1 (en) * 1997-01-30 1998-08-06 Yale University Diagnostic methods and compositions based on the distribution of rad51
EP1027444A1 (en) * 1997-10-31 2000-08-16 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
JP2001523472A (en) * 1997-11-18 2001-11-27 アボット・ラボラトリーズ Reagents and methods useful for detecting breast disease
CA2316397A1 (en) * 1997-12-24 1999-07-08 Corixa Corporation Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
WO2000008210A1 (en) * 1998-08-04 2000-02-17 Diadexus Llc A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer

Also Published As

Publication number Publication date
CA2368152A1 (en) 2000-09-21
WO2000055629A3 (en) 2001-03-22
WO2000055629A2 (en) 2000-09-21
EP1159619A2 (en) 2001-12-05

Similar Documents

Publication Publication Date Title
AU3752700A (en) Novel methods of diagnosing and treating breast cancer, compositions, and methods of screening for breast cancer modulators
AU2002245317A1 (en) Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
AU2002215345A1 (en) Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
AU2002249871A1 (en) Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators
AU2002347428A1 (en) Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
AU2002330039A1 (en) Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer
AU2002309583A1 (en) Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
AU1807401A (en) Compositions and methods for therapy and diagnosis of breast cancer
WO2002068677A8 (en) Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer
HUP0104717A3 (en) Compositions and methods for therapy and diagnosis of ovarian cancer
AU2002339865A1 (en) Methods and compositions useful for diagnosis, staging, and treatment of cancers and tumors
AU2010699A (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for theiruse
AU2002257004A1 (en) Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators
AU3755300A (en) Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
AU6902200A (en) Novel methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators
AU6468998A (en) Compositions and method for the early diagnosis of ovarian cancer
EP1007535A4 (en) Methods and compositions for diagnosis and treatment of breast cancer
AU3391200A (en) Compositions and methods for breast cancer therapy and diagnosis
IL132287A0 (en) Compositions and methods for the treatment and diagnosis of breast cancer
AU2001290902A1 (en) Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators
AU2596901A (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
AU8068198A (en) Methods for treating human cancers
AU5638400A (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU4977896A (en) Immunotherapy screening, prognosis, and treatment methods and compositions
AU2002357734A1 (en) Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase